Kiran Nakkala
Gastroenterology · Fayetteville, NCNPI 1326234600
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,647 of the $1,911 with a category attached, or 86.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $613 and has fallen 68.1% since, to $196 in 2025. That places this record below the midpoint for gastroenterology clinicians in NC, where the typical reported total is $1,694.
Across 82 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$448
- Apollo Endosurgery US Inc$337
- Takeda Pharmaceuticals U.S.A., Inc.$195
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$177
- Sanofi$120
- Regeneron Healthcare Solutions, Inc.$90
- plus $544 from 19 others
What the payments were for
- Consulting fees$161%
- Travel & lodging$22612%
- Food & beverage$1,64786%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $448 |
| Apollo Endosurgery US Inc | 4 | $337 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $195 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $177 |
| Sanofi | 4 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Gilead | 2 | $57 |
| Merck | 3 | $54 |
| Intercept Pharmaceuticals, Inc. | 3 | $47 |
| Boston Scientific | 1 | $44 |
| Ardelyx, Inc. | 2 | $39 |
| Pfizer | 2 | $37 |
| Johnson & Johnson | 2 | $32 |
| Enterra Medical, Inc. | 1 | $29 |
| Organon | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Medtronic | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Intra-sana Laboratories | 1 | $18 |
| Shionogi Inc | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $14 |
| CSL Behring | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Overstitch$226
How this compares
$1,911 in reported general payments places this provider in the 50th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 97 | $775 |
| Ciprofloxacin Hcl | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Fayetteville
- John PoulosFayetteville$407K
- Joseph HendersonFayetteville$28K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
- Manal AbdelmalekDurham$402K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.